1. Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
William L. Read, MD, Kevin T. Brumund, MD, FACS, Robert A. Weisman, MD, FACS, Angel Q. Nguyen, BA 
JAAD Case Reports 
Volume 1, Issue 3, Pages (May 2015)
DOI: /j.jdcr
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Case 2. Submental recurrence of SCCS before (5/30/2006) and after (6/22/2006) erlotinib.
JAAD Case Reports 2015 1, DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Case 2. Diffuse postoperative recurrence of SCCS before (1/30/207) and after (3/27/2007) erlotinib.
JAAD Case Reports 2015 1, DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

4. Fig 3
Case 3. Diffuse regional recurrence of SCCS before (6/15/2010) and after (10/12/10) erlotinib.
JAAD Case Reports 2015 1, DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

5. Fig 4
Case 5. New primary SCCS of skin of lip before (5/20/2007) and after (6/1/2007) erlotinib.
JAAD Case Reports 2015 1, DOI: ( /j.jdcr )
Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions